Effect of inositol and its derivatives on diabetes: a systematic review

Crit Rev Food Sci Nutr. 2019;59(7):1124-1136. doi: 10.1080/10408398.2017.1392926. Epub 2019 Jan 12.

Abstract

A growing body of research has investigated the association between inositol and diabetes. The purpose of this review is to report through a systematic way the current scientific evidence relating potential benefits of inositol isomers on diabetes/gestational diabetes. The screening of the studies published last decade was performed in 4 databases (Pubmed-Web of Science-The Cochrane Library-Lilacs). Among the 1640 studies identified in the search, only 26 studies had sufficient data to be included in the systematic review. The available literature suggests that inositol seems to be provide improvements in fasting blood glucose and other biochemical results, which are among the most important parameters in diabetic individuals. Although there are some studies demonstrating that inositol may be effective in prevention and treatment of diabetes/gestational diabetes, conduction of studies with larger sample and longer follow-up duration is required for it to be represented as an effective strategy in management of diabetes.

Keywords: D-chiro-inositol; Diabetes; gestational diabetes; inositol; myo-inositol.

Publication types

  • Systematic Review

MeSH terms

  • Animals
  • Blood Glucose / metabolism
  • Databases, Factual
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / prevention & control
  • Diabetes, Gestational / drug therapy*
  • Diabetes, Gestational / prevention & control*
  • Fasting
  • Female
  • Humans
  • Inositol / chemistry*
  • Inositol / therapeutic use*
  • Pregnancy

Substances

  • Blood Glucose
  • Inositol